Inserm Transfert
Acronym: IT
General Information
Identification Code: 190044226228-01
Website: [object Object]
Entity Form: Ltd
Registration Category: Companies & groups
Registration Date: 3/22/2017
Last Update: 4/3/2024
EP Accredited Number: 0
Mission & Interests
Goals: Private subsidiary of Inserm, Inserm Transfert manages every aspect of the promotion and transfer of knowledge obtained by Inserm’s research laboratories to industry, thereby helping to promote health innovation. Inserm Transfert focus on adding value and minimizing risk for innovative projects at pre-industrial stage, bridging discovery and clinical research. We put emphasis on identifying high-potential projects, implementing appropriate proof of concept and IP strategies, and setting up win-win/mutually beneficial industrial partnerships.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Banking and financial services
- Competition
- Consumers
- Institutional affairs
- Public health
- Regional policy
- Research and innovation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: EU legislatives proposals or policies pertaining to
- Pharmaceutical regulation and medicinal product marketing authorisation,
- Research and innovation,
- Public health (both human and animal and digital health data)
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 10 rue d'Oradour-sur-Glane
Post Code: 75015
City: Paris
Country: FRANCE
Phone: [object Object]
EU Office
Address: 10 rue d'Oradour-sur-Glane
Post Code: 75015
City: Paris
Country: FRANCE
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: EU grants that contribute to the operating costs
- We have a department dedicated to project management of EC projects. This department is made up of 25 people namely- Collaborative Research Funding - entirely dedicated since 2003 to support researchers in handling project management and reporting to European Commission. During the most recent closed financial year (2023) our company was a full partner of 34 EU funding projects and recevied prepayment for 23 projects.
Membership Information
Members10 Percent: 2
Members25 Percent: 1
Members50 Percent: 0
Members75 Percent: 0
Members: 3
Members F T E: 0.44999998807907104
Info Members: Our involvement begins (with INSERM), by raising topics that can be subject of a topic in the various EU work programs thanks to the French representative at the EU committee program, with the contribution of Catherine Clusel - Director of the Collaborative Research funding department (25%)
Our CEO Pascale Augé and Sandrine Ayuso - chief of staff - (10% each) act as Inserm Transfert representatives at national, european and international level.
Structure
Structure Type: Structure
Is Member Of: Inserm Transfert is the private subsidiary of the National Institut of Health and Medical research (INSERM) http://www.inserm.fr/inserm-transfert (https://www.inserm-transfert.fr/inserm-transfert-en/our-mission-and-successes/)
Organisation Members: Inserm Transfert is a member of the
- Reseau C.U.R.I.E https://www.curie.asso.fr/reseau-curie/qui-sommes-nous/administrateurs
- Association France Biotech https://france-biotech.fr/annuaire/?_annuaire=adherents&_company_name=Inserm%20Transfert
- Pascale Augé our CEO is a membre of the network AUTM-Association of University Technology Managers https://autm.net/